ITGB1 and breast cancer: Interrogation of the breast cancer KM plotter datasets showed that, in concordance with WAVE2 (Fig. 1G), increased levels of ITGB1 correlate with decreased survival probability of patients with breast cancer (Fig. 8C and D), while increased expression levels of miR-29a (Fig. 8D and E) and miR-29b (Fig. 8D and F) have the opposite effect.